Bayesian Capital Management LP bought a new stake in shares of Neogen Co. (NASDAQ:NEOG – Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 11,103 shares of the company’s stock, valued at approximately $175,000.
A number of other hedge funds have also modified their holdings of NEOG. Norges Bank bought a new position in shares of Neogen in the fourth quarter worth approximately $365,794,000. Baillie Gifford & Co. bought a new position in Neogen during the fourth quarter valued at $166,646,000. Vanguard Group Inc. lifted its position in Neogen by 9.3% during the fourth quarter. Vanguard Group Inc. now owns 19,546,737 shares of the company’s stock valued at $393,085,000 after purchasing an additional 1,663,125 shares during the last quarter. Bamco Inc. NY raised its stake in shares of Neogen by 10.3% in the first quarter. Bamco Inc. NY now owns 7,304,967 shares of the company’s stock valued at $115,272,000 after acquiring an additional 680,668 shares during the period. Finally, Trigran Investments Inc. purchased a new stake in shares of Neogen in the fourth quarter valued at $12,048,000. 96.73% of the stock is currently owned by institutional investors.
Neogen Trading Down 0.2 %
NEOG stock opened at $17.00 on Friday. The company has a market capitalization of $3.68 billion, a PE ratio of 1,701.70 and a beta of 1.20. Neogen Co. has a 12 month low of $11.46 and a 12 month high of $24.09. The firm’s 50-day moving average is $15.94 and its 200 day moving average is $15.27. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.82 and a quick ratio of 2.66.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on NEOG. Piper Sandler reduced their target price on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating on the stock in a research note on Monday, April 15th. StockNews.com raised shares of Neogen to a “sell” rating in a research note on Wednesday, July 10th.
Get Our Latest Stock Report on Neogen
Neogen Profile
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Further Reading
- Five stocks we like better than Neogen
- Canada Bond Market Holiday: How to Invest and Trade
- T-Mobile Stock Poised to Outperform Peers with Stellar Quarter
- Canadian Penny Stocks: Can They Make You Rich?
- Defense Stocks Soar to New Highs; Higher Highs Are Coming
- The 3 Best Fintech Stocks to Buy Now
- Generac Raises Guidance: Why Is the Stock Still a Hold?
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.